Parahemophilia: New insights into factor v deficiency

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 6, 2013, Pages 607-612

  Thalji, Nabil ^a   Camire, Rodney M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bleeding phenotype; factor V; factor V deficiency; hemostasis

Indexed keywords

ACTIVATED PROTEIN C; ACTIVATED PROTHROMBIN COMPLEX; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 5; COMPLEMENTARY DNA; ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT PROTEIN 53; FRESH FROZEN PLASMA; GESTAGEN; MESSENGER RNA; ORAL CONTRACEPTIVE AGENT; PROTHROMBIN COMPLEX; THROMBOCYTE FACTOR 5; TISSUE FACTOR PATHWAY INHIBITOR; TRANEXAMIC ACID;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; BIOCHEMISTRY; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CRYOPRECIPITATE; DEGRANULATION; DNA SEQUENCE; ENDOMETRIUM ABLATION; EPISTAXIS; GENE SEQUENCE; GENETIC ANALYSIS; HEMARTHROSIS; HEMOSTASIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYSTERECTOMY; INDEL MUTATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LABORATORY DIAGNOSIS; MEGAKARYOCYTE; MENORRHAGIA; MISSENSE MUTATION; MONOTHERAPY; MUCOSAL BLEEDING; MUSCLE HEMATOMA; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; NONSENSE MUTATION; ORAL BLEEDING; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PRIORITY JOURNAL; PROGESTIN IMPLANT; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTHROMBIN TIME; STOP CODON; THROMBOCYTE ACTIVATION; THROMBOCYTE POOR PLASMA; THROMBOCYTE TRANSFUSION; THROMBOSIS; TRANSIENT EXPRESSION;

BLOOD PLATELETS; FACTOR V; FACTOR V DEFICIENCY; GENETIC PREDISPOSITION TO DISEASE; HEMORRHAGE; HUMANS; MUTATION;

EID: 84883236723     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1349224     Document Type: Article

References (43)

1. Owren P. A. Parahaemophila: haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet: 1947; 249 446 448
2. Stormorken H. The discovery of factor V: a tricky clotting factor. J Thromb Haemost: 2003; 1 2 206 213
3. Mann K. G., Kalafatis M. Factor V: a combination of Dr Jekyll and Mr Hyde. Blood: 2003; 101 1 20 30
4. Camire R. M., Bos M. HA. The molecular basis of factor V and VIII procofactor activation. J Thromb Haemost: 2009; 7 12 1951 1961
5. Cripe L. D., Moore K. D., Kane W. H. Structure of the gene for human coagulation factor V. Biochemistry: 1992; 31 15 3777 3785
6. Kane W. H., Davie E. W. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proc Natl Acad Sci U S A: 1986; 83 18 6800 6804
7. Jenny R. J., Pittman D. D., Toole J. J., et al. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A: 1987; 84 14 4846 4850
8. Kane W. H., Ichinose A., Hagen F. S., Davie E. W. Cloning of cDNAs coding for the heavy chain region and connecting region of human factor V, a blood coagulation factor with four types of internal repeats. Biochemistry: 1987; 26 20 6508 6514
9. Wilson D. B., Salem H. H., Mruk J. S., Maruyama I., Majerus P. W. Biosynthesis of coagulation Factor V by a human hepatocellular carcinoma cell line. J Clin Invest: 1984; 73 3 654 658
10. Mazzorana M., Baffet G., Kneip B., Launois B., Guguen-Guillouzo C. Expression of coagulation factor V gene by normal adult human hepatocytes in primary culture. Br J Haematol: 1991; 78 2 229 235
11. Tracy P. B., Eide L. L., Bowie E. JW, Mann K. G. Radioimmunoassay of factor V in human plasma and platelets. Blood: 1982; 60 1 59 63
12. Mann K. G., Nesheim M. E., Church W. R., Haley P. E., Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood: 1990; 76 1 1 16
13. Asselta R., Peyvandi F. Factor V deficiency. Semin Thromb Hemost: 2009; 35 4 382 389
14. Duckers C., Simioni P., Rosing J., Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol: 2009; 146 1 17 26
15. Cui J., O'Shea K. S., Purkayastha A., Saunders T. L., Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature: 1996; 384 6604 66 68
16. Mannucci P. M., Peyvandi F., Franchini M. Rare inherited coagulation disorders other than hemophilia. In: Marder V. J., Aird W. C., Bennett J. S., Schulman S., White G. C., eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6th ed. Philadelphia, PA Lippincott Williams & Wilkins: 2013; 684 692
17. Acharya S. S., Coughlin A., Dimichele D. M. North American Rare Bleeding Disorder Study Group Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost: 2004; 2 2 248 256
18. Zhang B. Recent developments in the understanding of the combined deficiency of FV and FVIII. Br J Haematol: 2009; 145 1 15 23
19. Zhang B., Cunningham M. A., Nichols W. C., et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet: 2003; 34 2 220 225
20. Nichols W. C., Seligsohn U., Zivelin A., et al. Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping. J Clin Invest: 1997; 99 4 596 601
21. Neerman-Arbez M., Antonarakis S. E., Blouin J. L., et al. The locus for combined factor V-factor VIII deficiency (F5F8D) maps to 18q21, between D18S849 and D18S1103. Am J Hum Genet: 1997; 61 1 143 150
22. Franchini M., Lippi G. Acquired factor V inhibitors: a systematic review. J Thromb Thrombolysis: 2011; 31 4 449 457
23. Ortel T. L. Clinical and laboratory manifestations of anti-factor V antibodies. J Lab Clin Med: 1999; 133 4 326 334
24. Weiss H. J. Impaired platelet procoagulant mechanisms in patients with bleeding disorders. Semin Thromb Hemost: 2009; 35 2 233 241
25. Blavignac J., Bunimov N., Rivard G. E., Hayward C. P. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment. Semin Thromb Hemost: 2011; 37 6 713 720
26. ThoMurray J. M., Rand M. D., Egan J. O., Murphy S., Kim H. C., Mann K. G. Factor VNew Brunswick: Ala221-to-Val substitution results in reduced cofactor activity. Blood: 1995; 86 5 1820 1827
27. Paraboschi E. M., Kayiran S. M., Özbek N., et al. Functional characterization of a novel missense mutation identified in a Turkish patient affected by severe coagulation factor V deficiency. Haemophilia: 2012; 18 2 205 210
28. Lak M., Sharifian R., Peyvandi F., Mannucci P. M. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol: 1998; 103 4 1067 1069
29. Delev D., Pavlova A., Heinz S., Seifried E., Oldenburg J. Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency. Haemophilia: 2009; 15 5 1143 1153
30. Dahlbäck B., Villoutreix B. O. Molecular recognition in the protein C anticoagulant pathway. J Thromb Haemost: 2003; 1 7 1525 1534
31. Simioni P., Scudeller A., Radossi P., et al. "Pseudo homozygouso" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thromb Haemost: 1996; 75 3 422 426
32. Camire R. M., Pollak E. S., Kaushansky K., Tracy P. B. Secretable human platelet-derived factor V originates from the plasma pool. Blood: 1998; 92 9 3035 3041
33. Thomassen M. C., Castoldi E., Tans G., et al. Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool. Haematologica: 2003; 88 10 1150 1156
34. Gould W. R., Simioni P., Silveira J. R., Tormene D., Kalafatis M., Tracy P. B. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost: 2005; 3 3 450 456
35. Bouchard B. A., Williams J. L., Meisler N. T., Long M. W., Tracy P. B. Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost: 2005; 3 3 541 551
36. Bouchard B. A., Meisler N. T., Nesheim M. E., Liu C. X., Strickland D. K., Tracy P. B. A unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes. J Thromb Haemost: 2008; 6 4 638 644
37. Gould W. R., Silveira J. R., Tracy P. B. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem: 2004; 279 4 2383 2393
38. Duckers C., Simioni P., Spiezia L., et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood: 2010; 115 4 879 886
39. Castoldi E., Duckers C., Radu C., et al. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma. J Thromb Haemost: 2011; 9 5 959 968
40. Yang T. L., Cui J., Taylor J. M., Yang A., Gruber S. B., Ginsburg D. Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost: 2000; 83 1 70 77
41. Mann K. G. How much factor V is enough? Thromb Haemost: 2000; 83 1 3 4
42. Duckers C., Simioni P., Spiezia L., et al. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood: 2008; 112 9 3615 3623
43. Talbot K., Song J., Hewitt J., et al. A novel compensating mechanism for homozygous coagulation factor V deficiency suggested by enhanced activated partial thromboplastin time after reconstitution with normal factor V. Br J Haematol: 2010; 151 2 198 200